Results 11 to 20 of about 4,088,704 (313)

Calprotectin in Lung Diseases [PDF]

International Journal of Molecular Sciences, 2021
Calprotectin (CLP) is a heterodimer formed by two S-100 calcium-binding cytosolic proteins, S100A8 and S100A9. It is a multifunctional protein expressed mainly by neutrophils and released extracellularly by activated or damaged cells mediating a broad range of physiological and pathological responses.
Ourania S. Kotsiou, Dimitrios Papagiannis, Rodanthi Papadopoulou, Konstantinos I. Gourgoulianis   +3 more
openaire   +3 more sources

Lung transplantation for interstitial lung disease [PDF]

European Respiratory Review, 2021
Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire   +3 more sources

Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis

Diagnostics, 2022
Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still lacking. Most specialists use steroids as first-line drugs, sometimes
Katarzyna B. Lewandowska, Inga Barańska, Małgorzata Sobiecka, Piotr Radwan-Rohrenschef, Małgorzata Dybowska, Monika Franczuk, Adriana Roży, Agnieszka Skoczylas, Iwona Bestry, Jan Kuś, Witold Z. Tomkowski, Monika Szturmowicz   +11 more
doaj   +1 more source

Pulmonary amyloidosis mimicking interstitial lung disease and malignancy - A case series with a review of a pulmonary patterns

Respiratory Medicine Case Reports, 2021
Background: Amyloidosis is an uncommon condition, which results from accumulation of misfolded extracellular insoluble protein in tissues and organs of the body, causing its damage and dysfunction.
Katarzyna Zimna, Małgorzata Sobiecka, Renata Langfort, Katarzyna Błasińska, Witold Z. Tomkowski   +4 more
doaj   +1 more source

Tuberculous Pericarditis—Own Experiences and Recent Recommendations

Diagnostics, 2022
Tuberculous pericarditis (TBP) accounts for 1% of all forms of tuberculosis and for 1–2% of extrapulmonary tuberculosis. In endemic regions, TBP accounts for 50–90% of effusive pericarditis; in non-endemic, it only accounts for 4%.
Małgorzata Dybowska, Katarzyna Błasińska, Juliusz Gątarek, Magdalena Klatt, Ewa Augustynowicz-Kopeć, Witold Tomkowski, Monika Szturmowicz   +6 more
doaj   +1 more source

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy

Diagnostics, 2023
The prevalence of pulmonary hypertension (PH) complicating interstitial lung diseases (ILDs) is 3.5–15% at an early stage, and up to 90% in ILD patients listed for lung transplantation.
Aneta Kacprzak, Witold Tomkowski, Monika Szturmowicz   +2 more
doaj   +1 more source

Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery

Diagnostics, 2023
Sarcoidosis has been a well-recognised risk factor for pulmonary hypertension (PH) for a long time, but still, the knowledge about this concatenation is incomplete.
Aneta Kacprzak, Witold Tomkowski, Monika Szturmowicz   +2 more
doaj   +1 more source

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. [PDF]

, 2013
Recent data for the global burden of disease reflect major demographic and lifestyle changes, leading to a rise in non-communicable diseases. Most countries with high levels of tuberculosis face a large comorbidity burden from both non-communicable and ...
Abubakar, Ibrahim, Pletschette, Michel, Migliori, Giovanni Battistai, Migliori, Giovanni Battista, Zafar, Afia, Hoelscher, Michael, Pantaleo, Guiseppe, Kim, Peter, Lawn, Stephen D, Swaminathan, Soumya, Memish, Ziad A, Maeurer, Markus, Hasan, Rumina, Marais, Ben J., A Memish, Ziad, Marais, Ben J, Zumla, Alimuddin, Craig, Gill, Lawn, Stephen D., Glaziou, Philippe, Lönnroth, Knut, Mwaba, Peter, Schito, Marco, Zijenah, Lynn, Bates, Matthew, Memish, Ziad A., Colagiuri, Ruth, Mwaba, P., Zafar, A., Hasan, R., Zijenah, L., Marais, B.J., Glaziou, P., Kim, P., Abubakar, I., Pletschette, M., Lönnroth, K., Migliori, G.B., Hoelscher, M., Memish, Z.A., Bates, M., Craig, G., Lawn, S.D., Colagiuri, R., Pantaleo, G., Zumla, A., Schito, M., Maeurer, M., Swaminathan, S., Mwaba, P, Marais, BJ, Bates, M, Loennroth, K, Glaziou, P, Lawn, SD, Zijenah, L, Swaminathan, S, Colagiuri, R, Migliori, GB   +58 more
core   +1 more source

Serum Levels of Interleukin-8 and Tumor Necrosis Factor-alpha in Coal Workers' Pneumoconiosis: One-year Follow-up Study

Safety and Health at Work, 2010
Objectives: Various cytokines induced by inhalation of coal dust may mediate inflammation and lead to tissue damage or fibrosis, such as coal workers' pneumoconiosis (CWP).
Jong Seong Lee, Jae Hoon Shin, Joung Oh. Lee, Kyung Myung Lee, Ji Hong Kim, Byung-Soon Choi   +5 more
doaj   +1 more source

Lung Cancer in Pulmonary Fibrosis: Tales of Epithelial Cell Plasticity [PDF]

, 2011
Lung epithelial cells exhibit a high degree of plasticity. Alterations to lung epithelial cell function are critically involved in several chronic lung diseases such as pulmonary fibrosis.
Königshoff, M., Melanie Königshoff, Königshoff, Melanie   +2 more
core   +1 more source